Human serum paraoxonase (PON1) exists in 2 major polymorphic forms: Q (glutamine) or R (arginine) at codon 192. The PON1192 activity polymorphism is substrate dependent. The PON1Q192 isoform has a higher rate of in vitro hydrolysis of diazoxon, sarin, and soman, whereas the PON1R192 isoform has higher activity for the hydrolysis of paraoxon and chlorpyrifos oxon. Both isoforms hydrolyze phenyl acetate at approximately the same rate. The present study described and evaluated a kinetic method of arylesterase activity determination with a modified fixed incubation method that used the oxidative coupling of phenol with 4-aminoantipyrine of phenyl acetate as the substrate. Our improved method shows that arylesterase activity is lower with the PON1R192 isoform than with the PON1Q192 isoform. The average activities of serum of individuals of a specific PON1Q192 genotype showed higher arylesterase and lower paraoxonase activity than the PON1R192 genotype. The ratio of paraoxonase/arylesterase activity showed a clear separation of all three PON1192 genotypes with no overlap between the groups (QQ: < 5.0, QR: 5.0-11.0, RR: > 11.0). PCR has suggested that the PON1192 phenotypes correspond to the PON1192 genotypes. Therefore, when conducting epidemiological or mechanistic studies that examine the role of PON1 in organophosphorus or lipid metabolism, this ratio is more useful and informative than a PCR-based genotype alone. J Atheroscler Thromb, 2003; 10: 337-342.
Introduction
Human serum paraoxonase (PON1: aryldialkylphosphatase [E.C.3.1.8.1]) is a calcium-dependent glycoprotein that is tightly associated with apolipoprotein A-1 in HDL, hydrolysis aromatic carboxylic acid esters, organophosphate insecticides and nerve gases (1, 2) .
The gene for PON1 shows 2 common polymorphisms: Q (glutamine) or R (arginine) at codon 192 (3, 4) . The PON1192 activity polymorphism is substrate dependent. The PON1Q192 isoform has a higher rate of in vitro hydrolysis of diazoxon, sarin, and soman (5) , whereas the PON1R192 isoform has higher activity for the hydrolysis of paraoxon and chlorpyrifos oxon (6) . Both isoforms hydrolyze phenylacetate at approximately the same rate (7) .
Although the natural substrate for serum PON1 is unknown, the inverse relationship between serum paraoxonase activity and the risk for atherosclerotic disease (8) suggests that PON1 hydrolytic activity on oxidized phospholipids in LDL may be related to its antiatherogenicity (9) (10) (11) (12) . Several studies have reported that the PON1R192 allele is a risk factor for CHD in various populations (13) (14) (15) (16) (17) . These findings contrast with the assumptions that were held before the PON1Q192 allele's association with the highest paraoxonase activity towards certain substrates was recognized. Recently, Mackness et al. (7) reported in a group of normolipidemic subjects that in individuals with the PON1RR192 genotype, the protective effect of HDL against LDL oxidation was lower than that in subjects with the PON1QQ192 genotype. Therefore, the relationship between the PON1R192 allele and CHD could be better explained by in vitro rates of diazoxonase hydrolysis, as opposed to paraoxon hydrolysis which may be more predictive of in vivo rates of lipid hydroperoxides (18) .
Jarvik et al. (19) reported that the PON1 phenotype is a better predictor of vascular disease than the PON1192 or PON155 genotypes.
The present study described and evaluated a kinetic method of arylesterase determination with a modified fixed incubation method that used the oxidative coupling of phenol with 4-aminoantipyrine (20) . The improved method showed that mean serum arylesterase activity was lower in those with the PON1R192 isoform than in those with the PON1Q192 isoform. 
Materials and Methods

Chemicals
Serum samples
Blood samples were randomly collected by clean venipuncture from 127 apparently healthy Japanese subjects aged 38-73 years (42 males and 85 females) with informed consent. These samples were allowed to clot at room temperature for 2 to 4 hours and were centrifuged at 1,000 g for 10 min at room temperature. The serum that separated was transferred into 1.5 ml tubes and stored at -80˚C until they were used (within 6 months).
Assay of arylesterase activity
Arylesterase activity was measured using a centrifugal autoanalyzer (Cobas Fara; F. Hoffmann-La Roche Ltd., Basel, Switzerland). Serum samples were diluted 800 times with dilution buffer (pH 8.0) containing 10 mM EPPS, 1 mM CaCl2, 0.01% Triton X-100, and 5 mM cysteine. The diluted serum sample (10 µl) and 270 µl of 13 mM EPPS buffer (pH 8.0) containing 3.25 mM 4-aminoantipyrine, 1.3 mM CaCl2, 52 µM eserine, and 6 µM EDTA-2K, were mixed and incubated at 37˚C for 5 min. The enzyme-substrate reaction was initiated by addition of 70 µl of substrate solution containing 30 mM potassium ferricyanide, 200 mM phenyl acetate, and 8.0% Triton X-100. Final concentration of substrate was 40 mM of phenyl acetate. All the determined rates represent the initial rates of substrate hydrolysis. The change in absorbance at 510 nm was monitored at 15 s intervals for 2 to 5 min. In this assay, initial rates were linear for at least 2 to 5 min. Blanks without enzyme were used to correct for the spontaneous hydrolysis of phenylacetate. The millimolar absorptivity of the product (p-benzoquinone-monoimino)-phenazone2,6-dichloro-4-acetylphenol) was 13.51 l • mmol -1 • cm -1 at 510 nm. One unit of arylesterase activity is defined as 1 µmol of phenyl acetate hydrolyzed per min at 37˚C at pH 8.0.
Assay of paraoxonase activity
Paraoxonase activity was measured by adapting the procedure described by Furlong et al. (22) to a CobasFara centrifugal analyzer. The enzyme-substrate reaction was initiated by addition of 2.5 µl of serum sample to 250 µl of 100 mM Tris-HCl buffer (pH 8.5) containing 1.2 mM paraoxon, 1 mM CaCl2, and 2 M NaCl. The rate of hydrolysis was assessed by measuring p-nitrophenol at 405 nm at 37˚C. The change in absorbance was monitored at 15 s intervals for 1 to 5 min. Blanks without enzyme were used to correct for the spontaneous hydrolysis of paraoxon. A millimolar absorptivity of the paraoxon was 18.05 l • mmol -1 • cm -1 at 405 nm. One unit of paraoxonase activity was defined as 1 µmol of paraoxonase hydrolyzed per min at 37˚C at pH 8.5.
Paraoxonase genotyping
DNA was extracted from buffy coats as described by Blin et al. (23) , and the assays for genotyping two polymorphisms were based on changes in the enzyme digestion patterns as described by Humbert et al. (4) . Primers for amplification of a 99-bp DNA that contained the coding sequence for position 192 were 5'-T A T T G T T G C T G T G G G A C C T G A G -3 ' a n d 5 ' -CACGCTAAACCCAAATACATCTC-3'. Genomic DNA (1 µg) was amplified in 50 µl of reaction mixture containing 0.3 µmol/l of each primer, 200 µmol/l of each dNTP, 5 µl of 10 x reaction buffer [100 mmol/l Tris HCl (pH 9.0), 500 mmol/l KCl, and 1% Triton X-100], 5% DMSO, and 1.25 U Taq DNA polymerase. After the DNA was denatured for 5 min at 94˚C, the reaction mixture was subjected to 40 cycles of denaturation for 60 s at 94˚C, 45 s of annealing at 56˚C, and 45 s of extension at 72˚C. The amplified PCR products were digested with 8 U of Alw I for 3 hours at 37˚C. The digested products were then subjected to 3.0% agarose gel electrophoresis and visualized with ethidium bromide staining. The allele PON1Q192 corresponded to a 99-bp fragment and the allele PON1R192 to 65-and 34-bp fragments.
Statistics
All values were expressed as means ± SD. Statistical significance was evaluated using Student's t-test for unpaired data.
Results
Substrate concentration
The dependence of serum arylesterase activity on the reaction mixture's substrate concentration was followed up to 50 mmol/l. These amounts of phenyl acetate could not completely dissolve in water. Therefore, phenyl acetate was dissolved using 80 g/l of Triton X-100. Triton X-100 did not influence the measurement of arylesterase activity (data not shown). The maximum arylesterase activity was greater in the 30 mmol/l of phenyl acetate using three PON1192 isoform (QQ, QR, RR) individual serum samples (Fig. 1) . The Km value for PON1QQ192, PON1QR192, and PON1RR192 of arylesterase activity was 5.9, 3.8, and 3.4 mmol/l, respectively.
Effectors on serum dilution
The inhibitory effects on the dilute solution are summarized in Fig. 2 . Both serum diluted by distilled water and CaCl2 in distilled water decreased, time dependently, the arylesterase activity in 24 h at 25˚C. The addition of EPPS, Triton X-100, and CaCl2 in the dilute solution could not maintain the full activity of the samples for 24 h at 25˚C, but the addition of cysteine, glutathione, or mercaptoethanol could maintain the full activity.
Effect of storage
In view of the labile nature of arylesterase activity, we examined the effect of storage temperature (23-27˚C, 3-6˚C, and -80˚C) on the stability of arylesterase activity in serum samples collected from five healthy individuals. Arylesterase activity in these samples did not change within one week at 23-27˚C or at 3-6˚C, and did not change after 6 months at -80˚C. 
Assay imprecision
The within-and between-run imprecision was evaluated using two different serum samples assayed 20 times each. Aliquots of the serum samples were stored at -80˚C until use. The within-run CVs of arylesterase activity were 1.4% (at 225 KU/l) and 1.8% (at 101 KU/l), respectively. The between-run CVs were 1.9% (at 225 KU/l) and 2.9% (at 101 KU/l), respectively. The upper limit of linearity of the present arylesterase assay, determined by measuring serum, was 400 KU/l. Table 1 shows the population distribution plots of paraoxonase versus arylesterase activity; PON1192 genotypes were clearly distinguishable by the ratio of paraoxonase/arylesterase activity: QQ: < 5.0, QR: 5.0-11.0, RR: > 11.0. In each PON1192 genotype the amount of paraoxonase activity correlated linearly with the amount of arylesterase activity (Fig. 3) . The PON1Q192 isoform showed higher arylesterase and lower paraoxonase activity than the PON1R192 isoform. When compared with other Caucasian studies, the present findings of the PON1RR192 genotype's higher frequency are similar to previous observations in a Japanese study (17) .
Population distribution of paraoxonase versus arylesterase activity
Discussion
Proper substrate concentration and dilute serum solution improve the accuracy and sensitivity of the measurement for arylesterase activity. Although the Km for arylesterase using phenyl acetate as the substrate is about 1 mmol/l (20, 24) , previous studies used 1 to 10 mmol/l concentrations of phenyl acetate as the substrate, which is low with respect to the Km value (20, 25, 26) . Therefore, the arylesterase activity could not show the full activity of PON1 and both PON1192 isoforms hydrolyzed phenyl acetate at approximately the same rate (7) .
In this study, we used a 40 mmol/l concentration of phenyl acetate as the substrate, a concentration that showed the full hydrolytic activity of PON1192. The average activities of serum of individuals of a specific PON1Q192 genotype showed higher arylesterase and lower paraoxonase activity than those of the PON1R192 genotype. The ratio of paraoxonase to arylesterase activity showed a clear separation among all three PON1192 phenotypes with no overlap between the groups. PCR has suggested that the PON1192 phenotypes correspond to the PON1192 genotypes. Davies et al. (5) recently reported that PON1192 polymorphism's effect on the hydrolysis of diazoxon, soman and sarin was reversed when compared that of to paraoxonase. The PON1QQ192 and PON1RR192 hydrolysis activities on diazoxon, soman and sarin, however, overlapped each other. Otherwise, the PON1QQ192 arylesterase activity of our result was significantly higher than that of PON1RR192.
Because of high arylesterase activity, human serum must be diluted; doing so, however, inactivates the enzyme. By adding calcium, this was prevented (20) . Calcium stabilizes the enzyme and reduces the influence of proteins on substrate hydrolysis (27) . The present findings show that to stabilize diluted serum arylesterase activity, it is necessary to also add Triton X-100, EPPS, and cysteine. In this study, sulfydryl reagents were used to inhibit paraoxonase activity and cysteine was used to reverse this process (28) . The addition of 2-mercaptoethanol and cysteine to assay mixtures that were free from calcium activated arylesterase activity (20) . Liver-derived choline esterase has been known to reside in serum. The assay we described in this article may measure the activity for aryleastrase and choline esterase together. With this method, we diluted serum to 800 times because of the extremely high activity of arylesterase. Normal activity of serum choline esterase, therefore, can be ignored in the diluted condition.
Previous studies have examined the relationship between the PON1192 genotype and cardiovascular disease in populations of varying ethnicities. While some reported a correlation between the PON1R192 allele and disease (13) (14) (15) (16) (17) , other studies have failed to find a connection (29) (30) (31) . This discrepancy may partly be due to variation in paraoxonase and arylesterase activity levels within the same genotype. A second PON1 polymorphism at position 55 (leu/met) has been reported to influence the levels of serum PON1 (32) . The PON1L55 allele appears to be associated with higher PON1 levels. The ratio of paraoxonase/ arylesterase activity may not correlate only with the PON1192 polymorphism. Consequently, when conducting epidemiological or mechanistic studies that examine the role of PON1 in organophosphorus or lipid metabolism, this ratio is more useful and informative than a PCRbased genotype alone.
